0
0
42 words
0
Comments
Researchers say GLP-1 drugs used to treat type 2 diabetes such as Ozempic, Wegovy, and Mounjaro do not raise a person's risk of pancreatic cancer
You are the first to view
https://www.medicalnewstoday.com/articles/ozempic-wegovy-other-glp1-drugs-not-linked-to-pancreatic-cancer-risk-study-finds
Create an account or login to join the discussion